Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Ivermectin 3 MG
DRUG
3 trials
Sponsors
Kitasato University
, Jennifer Keiser
Conditions
Covid19
Helminthiasis
Intestinal Worms
Strongyloides Stercoralis Infection
Phase 2
Study in COvid-19 Patients With iveRmectin (CORVETTE-01)
NCT04703205
Kitasato University
Covid19
Start: 2020-09-16
End: 2022-05-31
Updated: 2022-01-20
Phase 3
Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis
Completed
NCT04848688
Jennifer Keiser
Strongyloides Stercoralis Infection
Start: 2022-02-05
End: 2022-07-17
Updated: 2024-01-25
Unknown Phase
Co-administration of IVM and ALB in School-based Deworming in Uganda
Completed
NCT06497075
Jennifer Keiser
Helminthiasis, Intestinal Worms
Start: 2024-07-01
End: 2024-10-19
Updated: 2024-12-20
Related Papers
Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial.
2023-11-07
10 citations
Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
Frontiers in Medicine
2023-05-22
5 citations
Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.
2022-10-28
16 citations